Nice post, gotta look at the big picture.
BTW the big pic is look'n very promising.


GLTU

Yup you know it, folks are learning about this incredible story.

Nice post.

Your published price target.

Not long ago it was $6.00; what happened? lol

Don't worry we will still get there.

ELTP number 8 on ihub most active forums.

You bet ya!

"What drug launch?"
I don't know the last 6 or 7.

Just like it has been stated that none of the below 8kable events will happen.
Pretty laughable.



Rodman & Renshaw Conference
Isradipine 2.5 mg and 5.0 mg capsules Approval
Isradipine 2.5 mg and 5.0 mg capsules Launch
Dantrolene Sodium 25 mg, 50 mg and 100 mg capsules Approval
Dantrolene Sodium 25 mg, 50 mg and 100 mg capsules Launch
Loxapine 5mg, 10mg, 25 mg, 50 mg capsules Approval
Loxapine 5mg, 10mg, 25 mg, 50 mg capsules Launch
Hydroxyzine HCI 10 mg, 25 mg, 50 mg tablets Approval
Hydroxyzine HCI 10 mg, 25 mg, 50 mg tablets Launch
ELI-201 Pivotal BE Results
ELI-202 Pivotal BE Results
ELI-200 In Vitro Lab Abuse Study Results
ELI-200 In Vivo Human Abuse Liability Results
ELI-202 In Vitro Lab Abuse Study Results
ELI-202 In Vivo Human Abuse Liability Results
ELI-203 Pivotal BE Study Initiation
Partnership announcement(s)
November 2014 Conference Call
December ELI-200 NDA ART FDA Filing

Wow super cool.
I would love to hear more as things develop.

Heard it all before every drug launch, transfer and financing. Never going to happen. But they do.

Right on.
NH has over and over again, and will, deliver.

"and no dilution WEIGHTED AVERAGE SHARES OUTSTANDING 9,150,534 "

This is great news to me.

GLTU

'They're all happening in the next 4 months."

I am very ready and willing to be wrong, just be surprised if everyone them happens.


I do agree they are all on deck.
GLTU

ELTP

I agree 100%.
The list is a list of potential pr's. I would be shocked if all of them were accomplished in 4 months as this industry is full of delay's. I will be disappointed if the FDA holds them up on filling a NDA for their first ART/ADT. It could happen but will only delay the inevitable," buyout.".

GLTU

******************NEXT 4 MONTHS******************** ?

Rodman & Renshaw Conference
Isradipine 2.5 mg and 5.0 mg capsules Approval
Isradipine 2.5 mg and 5.0 mg capsules Launch
Dantrolene Sodium 25 mg, 50 mg and 100 mg capsules Approval
Dantrolene Sodium 25 mg, 50 mg and 100 mg capsules Launch
Loxapine 5mg, 10mg, 25 mg, 50 mg capsules Approval
Loxapine 5mg, 10mg, 25 mg, 50 mg capsules Launch
Hydroxyzine HCI 10 mg, 25 mg, 50 mg tablets Approval
Hydroxyzine HCI 10 mg, 25 mg, 50 mg tablets Launch
ELI-201 Pivotal BE Results
ELI-202 Pivotal BE Results
ELI-200 In Vitro Lab Abuse Study Results
ELI-200 In Vivo Human Abuse Liability Results
ELI-202 In Vitro Lab Abuse Study Results
ELI-202 In Vivo Human Abuse Liability Results
ELI-203 Pivotal BE Study Initiation
Partnership announcement(s)
November 2014 Conference Call
December ELI-200 NDA ART FDA Filing

Money speaks very loud to me and NH has spoken. with his own money. Glad I listened to the ceo money speak and not folks who think the company is junk.

BTW his money is still speaking, everyday he does not sell his shares is a day he believes he will get more for his shares down the road. Me to.

GLTA Longs

LOL 800k below .12. According to your posts.
You and me both, I invested a bunch and am waiting for art/adt launch.

I am going to be able to pick up a few more next week.
IMO its very cheap in the low .30s.

ELTP

"Just beware of the pump and dump that is occurring"

LOL I remember I got the same warning at, let me see.06.

ELTP GLTA Lomgs

How did you discover ELTP?

Welcome aboard.

Not much available below .34.

Those investing now won't have to wait three years like those who bought in 2011 for the returns we have. Maybe 6-8 months. Me, I will wait for NH to sell his shares, which he will do when Elite is bought out. Those who are patient will be richly rewarded.

GLTA Longs

I got an e-mail from the company earlier in the month from Verlin
Sneller from this e-mail: vsneller@mtcnet.net. I had asked if the 10-Q
would be on time.

We know how that turned out. Hope they report even more revenue in this
quarter. That $1.7 million was a big surprise to me. Hope we have more
to come.

Lots of folks sold before the last big run. Bored of ELTP, need money moving on to another stock.


Not me.

This what to expect in the next four months.


Rodman & Renshaw Conference
Isradipine 2.5 mg and 5.0 mg capsules Approval
Isradipine 2.5 mg and 5.0 mg capsules Launch
Dantrolene Sodium 25 mg, 50 mg and 100 mg capsules Approval
Dantrolene Sodium 25 mg, 50 mg and 100 mg capsules Launch
Loxapine 5mg, 10mg, 25 mg, 50 mg capsules Approval
Loxapine 5mg, 10mg, 25 mg, 50 mg capsules Launch
Hydroxyzine HCI 10 mg, 25 mg, 50 mg tablets Approval
Hydroxyzine HCI 10 mg, 25 mg, 50 mg tablets Launch
ELI-201 Pivotal BE Results
ELI-202 Pivotal BE Results
ELI-200 In Vitro Lab Abuse Study Results
ELI-200 In Vivo Human Abuse Liability Results
ELI-202 In Vitro Lab Abuse Study Results
ELI-202 In Vivo Human Abuse Liability Results
ELI-203 Pivotal BE Study Initiation
Partnership announcement(s)
November 2014 Conference Call
December ELI-200 NDA ART FDA Filing

Ya it sure looks that way. These .30's will be spoken of as the .06 of the past with what we have coming this fall.

Rodman & Renshaw Conference
Isradipine 2.5 mg and 5.0 mg capsules Approval
Isradipine 2.5 mg and 5.0 mg capsules Launch
Dantrolene Sodium 25 mg, 50 mg and 100 mg capsules Approval
Dantrolene Sodium 25 mg, 50 mg and 100 mg capsules Launch
Loxapine 5mg, 10mg, 25 mg, 50 mg capsules Approval
Loxapine 5mg, 10mg, 25 mg, 50 mg capsules Launch
Hydroxyzine HCI 10 mg, 25 mg, 50 mg tablets Approval
Hydroxyzine HCI 10 mg, 25 mg, 50 mg tablets Launch
ELI-201 Pivotal BE Results
ELI-202 Pivotal BE Results
ELI-200 In Vitro Lab Abuse Study Results
ELI-200 In Vivo Human Abuse Liability Results
ELI-202 In Vitro Lab Abuse Study Results
ELI-202 In Vivo Human Abuse Liability Results
ELI-203 Pivotal BE Study Initiation
Partnership announcement(s)
November 2014 Conference Call
December ELI-200 NDA ART FDA Filing

******************NEXT 4 MONTHS******************** ?

Rodman & Renshaw Conference
Isradipine 2.5 mg and 5.0 mg capsules Approval
Isradipine 2.5 mg and 5.0 mg capsules Launch
Dantrolene Sodium 25 mg, 50 mg and 100 mg capsules Approval
Dantrolene Sodium 25 mg, 50 mg and 100 mg capsules Launch
Loxapine 5mg, 10mg, 25 mg, 50 mg capsules Approval
Loxapine 5mg, 10mg, 25 mg, 50 mg capsules Launch
Hydroxyzine HCI 10 mg, 25 mg, 50 mg tablets Approval
Hydroxyzine HCI 10 mg, 25 mg, 50 mg tablets Launch
ELI-201 Pivotal BE Results
ELI-202 Pivotal BE Results
ELI-200 In Vitro Lab Abuse Study Results
ELI-200 In Vivo Human Abuse Liability Results
ELI-202 In Vitro Lab Abuse Study Results
ELI-202 In Vivo Human Abuse Liability Results
ELI-203 Pivotal BE Study Initiation
Partnership announcement(s)
November 2014 Conference Call
December ELI-200 NDA ART FDA Filing

Yes sir, we will make it with one ART/ADT product, plus the fact the market will know many many more are coming. NH owns 23% of the shares and has not sold a share, I won't sell until he does. Which will happen when Elite is bought out.

GLTA Longs

Acting like we will see news Thursday.
Don't really care, won't sell until NH sells.

GLTA Longs

Congrats, very nice size chunk.
IMO you have made a very wise choice.

In most cases 200dma is both a floor and a ceiling. I really think in this case we will move up through it, with average volume. But it really is of no matter, the fire works are about to start.

GLTA Longs

ELTP

"Over $1.7 Million in revenue is something to crow about. "

Yes it is. They may be waiting to let the investment world know until after the holiday. IMO vrty is way way undervalued.

ELTP is going to be a monster
Rev growing at over 70 % average per Q over last 7 quarters.
Look whats on deck.

******************NEXT 4 MONTHS******************** ?

Rodman & Renshaw Conference
Isradipine 2.5 mg and 5.0 mg capsules Approval
Isradipine 2.5 mg and 5.0 mg capsules Launch
Dantrolene Sodium 25 mg, 50 mg and 100 mg capsules Approval
Dantrolene Sodium 25 mg, 50 mg and 100 mg capsules Launch
Loxapine 5mg, 10mg, 25 mg, 50 mg capsules Approval
Loxapine 5mg, 10mg, 25 mg, 50 mg capsules Launch
Hydroxyzine HCI 10 mg, 25 mg, 50 mg tablets Approval
Hydroxyzine HCI 10 mg, 25 mg, 50 mg tablets Launch
ELI-201 Pivotal BE Results
ELI-202 Pivotal BE Results
ELI-200 In Vitro Lab Abuse Study Results
ELI-200 In Vivo Human Abuse Liability Results
ELI-202 In Vitro Lab Abuse Study Results
ELI-202 In Vivo Human Abuse Liability Results
ELI-203 Pivotal BE Study Initiation
Partnership announcement(s)
November 2014 Conference Call
December ELI-200 NDA ART FDA Filing

Nice post. I did not realize how many potential pr's we had on deck. I was looking for the big ones.


What will the price be at the end of the
******************NEXT 4 MONTHS******************** ?

Rodman & Renshaw Conference
Isradipine 2.5 mg and 5.0 mg capsules Approval
Isradipine 2.5 mg and 5.0 mg capsules Launch
Dantrolene Sodium 25 mg, 50 mg and 100 mg capsules Approval
Dantrolene Sodium 25 mg, 50 mg and 100 mg capsules Launch
Loxapine 5mg, 10mg, 25 mg, 50 mg capsules Approval
Loxapine 5mg, 10mg, 25 mg, 50 mg capsules Launch
Hydroxyzine HCI 10 mg, 25 mg, 50 mg tablets Approval
Hydroxyzine HCI 10 mg, 25 mg, 50 mg tablets Launch
ELI-201 Pivotal BE Results
ELI-202 Pivotal BE Results
ELI-200 In Vitro Lab Abuse Study Results
ELI-200 In Vivo Human Abuse Liability Results
ELI-202 In Vitro Lab Abuse Study Results
ELI-202 In Vivo Human Abuse Liability Results
ELI-203 Pivotal BE Study Initiation
Partnership announcement(s)
November 2014 Conference Call
December ELI-200 NDA ART FDA Filing

If you answered the questions, (lol) what post was it?

I remember asking you a ways back, I never got a straight answer to this question. What ADT/ART method do you think is better than Elites approach and why will it better inhibit abuse"?

Why do you think Elite's method is flawed or will fail.

"This past year was elite's BEST YEAR EVER for revenues."

What is that like 70$ average increase per Q over the last 6 quarters.
IMO the engines are not even warmed up. Those numbers will look small once Elite's ART/ADT hit the market.

ELTP Since 2011

Thanks Hike!!

"you are stupid environment if you believe anything that I say."

No one will ever be able to call me a "stupid environment"

I think we will be much higher than .32ish heading into October.
We shall see.

Amy way this is going a great ride.
IMO a buyout happens sometime before the first ART launch.

ELTP

I agree, under the radar.

That will all change in a few short weeks.

GLTA Longs